Lotus Pharmaceutical Co., Ltd. (1795.TW)
TWD 210.0
(-1.41%)
TWD 210.0
(-1.41%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 15.72 TWD | 35.63% |
| 2022 | 11.59 TWD | 110.73% |
| 2021 | 5.50 TWD | 30.02% |
| 2020 | 4.23 TWD | 36.01% |
| 2019 | 3.11 TWD | 640.48% |
| 2018 | 0.42 TWD | 366.67% |
| 2017 | 0.09 TWD | 116.07% |
| 2016 | -0.56 TWD | -227.27% |
| 2015 | 0.44 TWD | 118.26% |
| 2014 | -2.41 TWD | -156.38% |
| 2013 | -0.94 TWD | 78.29% |
| 2012 | -4.33 TWD | -428.05% |
| 2011 | -0.82 TWD | -364.52% |
| 2010 | 0.31 TWD | 276.21% |
| 2009 | 0.08 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 3.96 TWD | 162.25% |
| 2024 Q2 | 5.09 TWD | 28.54% |
| 2023 Q4 | 1.51 TWD | -68.28% |
| 2023 Q2 | 4.85 TWD | 5.9% |
| 2023 Q3 | 4.76 TWD | -1.86% |
| 2023 FY | - TWD | 35.63% |
| 2023 Q1 | 4.58 TWD | 615.63% |
| 2022 FY | - TWD | 110.73% |
| 2022 Q3 | 7.97 TWD | 532.54% |
| 2022 Q4 | 0.64 TWD | -91.97% |
| 2022 Q1 | 1.72 TWD | 77.32% |
| 2022 Q2 | 1.26 TWD | -26.74% |
| 2021 Q3 | 1.34 TWD | -2.9% |
| 2021 Q4 | 0.97 TWD | -27.61% |
| 2021 FY | - TWD | 30.02% |
| 2021 Q1 | 1.85 TWD | 41.22% |
| 2021 Q2 | 1.38 TWD | -25.41% |
| 2020 Q1 | 0.54 TWD | -5.26% |
| 2020 Q4 | 1.31 TWD | 13.91% |
| 2020 Q2 | 1.23 TWD | 127.78% |
| 2020 Q3 | 1.15 TWD | -6.5% |
| 2020 FY | - TWD | 36.01% |
| 2019 Q2 | 0.20 TWD | -82.76% |
| 2019 Q4 | 0.57 TWD | -30.49% |
| 2019 FY | - TWD | 640.48% |
| 2019 Q1 | 1.16 TWD | 286.67% |
| 2019 Q3 | 0.82 TWD | 310.0% |
| 2018 Q2 | -0.23 TWD | -428.57% |
| 2018 FY | - TWD | 366.67% |
| 2018 Q4 | 0.30 TWD | 7.14% |
| 2018 Q3 | 0.28 TWD | 221.74% |
| 2018 Q1 | 0.07 TWD | 610.95% |
| 2017 Q2 | 0.15 TWD | 150.0% |
| 2017 FY | - TWD | 116.07% |
| 2017 Q4 | -0.01 TWD | -106.85% |
| 2017 Q1 | -0.30 TWD | 62.03% |
| 2017 Q3 | 0.20 TWD | 33.33% |
| 2016 Q1 | 0.27 TWD | 125.0% |
| 2016 Q4 | -0.79 TWD | -464.29% |
| 2016 Q3 | -0.14 TWD | -300.0% |
| 2016 FY | - TWD | -227.27% |
| 2016 Q2 | 0.07 TWD | -74.07% |
| 2015 FY | - TWD | 118.26% |
| 2015 Q3 | 0.06 TWD | -83.78% |
| 2015 Q4 | 0.12 TWD | 100.0% |
| 2015 Q2 | 0.37 TWD | 384.62% |
| 2015 Q1 | -0.13 TWD | 85.56% |
| 2014 Q1 | -0.34 TWD | -30.77% |
| 2014 Q4 | -0.90 TWD | -104.55% |
| 2014 Q3 | -0.44 TWD | 73.33% |
| 2014 Q2 | -1.65 TWD | -385.29% |
| 2014 FY | - TWD | -156.38% |
| 2013 Q1 | 0.52 TWD | 130.59% |
| 2013 Q4 | -0.26 TWD | 18.75% |
| 2013 Q3 | -0.32 TWD | -166.67% |
| 2013 Q2 | -0.12 TWD | -123.08% |
| 2013 FY | - TWD | 78.29% |
| 2012 FY | - TWD | -428.05% |
| 2012 Q1 | -0.77 TWD | -1525.93% |
| 2012 Q2 | -1.79 TWD | -132.47% |
| 2012 Q3 | 0.04 TWD | 102.12% |
| 2012 Q4 | -1.70 TWD | -4585.49% |
| 2011 Q1 | -0.05 TWD | -112.97% |
| 2011 Q2 | 1.49 TWD | 3290.58% |
| 2011 Q3 | -2.29 TWD | -253.69% |
| 2011 Q4 | 0.05 TWD | 102.36% |
| 2011 FY | - TWD | -364.52% |
| 2010 Q3 | 0.03 TWD | -81.88% |
| 2010 Q2 | 0.16 TWD | 166.67% |
| 2010 Q1 | -0.24 TWD | 0.0% |
| 2010 Q4 | 0.36 TWD | 1141.38% |
| 2010 FY | - TWD | 276.21% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Grape King Bio Ltd | 9.81 TWD | -60.245% |
| Standard Chem & Pharm CO., LTD. | 4.67 TWD | -236.617% |
| Maywufa Company Ltd. | 1.27 TWD | -1137.795% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | -4266.667% |
| LIWANLI Innovation Co., Ltd. | 0.06 TWD | -24734.123% |
| YungShin Global Holding Corporation | 3.11 TWD | -405.466% |
| PhytoHealth Corporation | -0.24 TWD | 6650.0% |
| SCI Pharmtech, Inc. | 2.70 TWD | -482.222% |
| Formosa Laboratories, Inc. | 1.05 TWD | -1397.143% |
| PharmaEssentia Corporation | -1.93 TWD | 914.508% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 47.947% |